Here's Why Barclays Is Bullish On Intercept Pharma
June 01, 2016 at 08:54 AM EDT
Intercept Pharmaceuticals Inc’s (NASDAQ: ICPT) liver drug Ocaliva has been granted accelerated approval by the FDA. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.